Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Free Radic Biol Med. 2009 Oct 2;48(1):1. doi: 10.1016/j.freeradbiomed.2009.09.026

Fig 5. GSH and TGF-β-mediated fibrogenesis.

Fig 5

TGF-β decreases intracellular GSH by suppressing the expression of glutamate cysteine ligase (GCL), the rate-limiting enzyme in de novo GSH synthesis. On the other hand, GSH suppresses TGF-β-induced fibrogenic effects by reducing intracellular ROS levels and by preventing oxidative modifications/inactivation of MAPK phosphatases and thus MAPK activation. GSH may also block TGF-β-induced Smad pathway activity indirectly by inhibiting MAPK pathways.